Winning at all costs comes at a price; collateral issues of rivalry, arrogance, selfishness and a lack of humility and generosity.
—ANTHONY SALZ, with Russell Collins,
Salz Review: An Independent Review of
Barclays’ Business Practices, 2013
In the summer of 1951, Harper’s magazine gushed over “an unrestrained, dramatic race involving a dozen of the largest American drug houses, several leading foreign pharmaceutical manufacturers, three governments and more research personnel than have worked on any medical problem since penicillin.”1 What was all the excitement about? The prospect of manufacturing ...